Secteur Replimune Group, Inc. BOERSE MUENCHEN

Actions

7R8

US76029N1063

Recherche biotechnologique et médicale

Temps réel BOERSE MUENCHEN 10:44:18 24/06/2026 Varia. 5j. Varia. 1 janv.
9,886 EUR -1,39% Graphique intraday de Replimune Group, Inc. +33,49% +22,26%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+1,71%+6,10%+6,49%+9,80%-2,68%-8,18%+0,31%-21,15%+229,39% 44,45 Md
+2,23%+8,26%+11,84%+75,42%+112,82%+323,35%+564,22%+416,01% - 36,04 Md
+1,59%+4,63%-11,00%+0,51%-9,11%+7,23%+54,02%-19,31%+798,28% 30,7 Md
+2,07%-4,40%+2,01%+2,59%-24,01%+10,38%-19,99%-29,31%+163,43% 28,59 Md
-4,75%-8,02%-15,19%-10,50%-6,89%+5,99%+12,28%-30,65%+140,17% 23,01 Md
+4,64%+3,20%-3,42% - - - - - - 14,82 Md
+3,91%+2,57%+9,40%+3,62%-15,70%+53,41%+111,95%+169,21% - 13,52 Md
+1,32%+5,66%+4,49%+8,33%+5,90%+9,44%+17,71%-30,42%+105,12% 12,98 Md
+0,13%+3,97%+0,57%+7,35%-3,94%+101,73%+91,70%+101,14%+221,99% 12,56 Md
+1,38%-0,61%+22,17%+42,17%-21,70%-3,14%-36,96%-32,29%+111,65% 10,92 Md
+0,25%+55,89%+63,73%+67,69%+76,05%+221,35% - - - 9,96 Md
+2,78%+0,98%+16,41%+18,10%-6,46%+26,61%-10,21%-49,15%+121,67% 8,99 Md
+1,17%+0,41%+16,70%+8,19%-4,34%+14,12%-26,57%-49,36%+99,61% 8,81 Md
+1,59%-3,86%+5,26%-1,08%-17,68%-25,96% - - - 8,73 Md
+0,65%+18,71%-11,12%+3,83%+3,61%+633,53%+1 685,79%+5,32% - 8,51 Md
-1,21%+12,36%+24,54%+27,66%+26,27%+112,25%+327,73%+120,59% - 8,08 Md
+0,18%-2,94%-25,46%-11,91%-28,74%+1 432,14%+445,80%+180,39%+1 702,52% 7,77 Md
-1,26%+11,93%+10,16%+54,31%+47,99%+143,18%+88,76%+242,00% - 7,72 Md
+4,45%+9,03%+30,62%+73,48%+71,80%+64,29%+44,18%+98,88%+9,87% 8,01 Md
Moyenne +1,14%+6,62%+8,33%+21,09%+11,29%+173,43%+209,42%+66,99%+336,70% 16,01 Md
Moyenne pondérée par Capi. +1,23%+4,84%+5,51%+19,99%+13,38%+122,43%+167,68%+69,95%+321,42%
Recherche biotechnologique et médicale - Autres
  1. Bourse
  2. Actions
  3. Action REPL
  4. Action 7R8
  5. Secteur Replimune Group, Inc.
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT